Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy

Clinical trial NCT04305613 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04305613
Sponsor: Abramson Cancer Center at Penn Medicine
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Cardiotoxicity Lung Cancer Stage III Lung Cancer Stage II Radiation Toxicity

Start date: 2020-09-14
Primary completion: 2026-09-01
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.